By Michael Erman and Puyaan Singh July 15 (Reuters) – Johnson & Johnson said on Wednesday that its medical device unit underperformed in the second quarter, even as strong sales of Tremfya for
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Moroccan rapper El Mahdi Lyoubi held in pre-trial detention, rights group says
RABAT, July 16 (Reuters) - Casablanca's public prosecutor ordered rapper and documentary filmmaker El Mahdi…
Brookfield-backed Csquare prices IPO at $21 per share, Bloomberg News reports
July 15 (Reuters) - Data center provider Csquare priced its initial public offering at $21…
TSMC's second-quarter profit seen hitting record on AI boom
By Wen-Yee Lee and Ben Blanchard TAIPEI, July 16 (Reuters) - TSMC, the world's largest…
